Skip to main content
. 2016 Jun 24;6(6):383–390. doi: 10.1016/j.jfms.2004.02.001

Figure 13.

Figure 13

A diabetic Himalayan cat with invasive nasal aspergillosis due to Aspergillus flavus and secondary involvement of the nasal bridge/forehead. This cat developed hepatotoxicosis during itraconazole therapy (even at doses as low as 25 mg daily) but eventually responded to improved glycaemic control, twice weekly amphotericin B infusions (see Figure 11) and terbinafine (62.5 mg once daily).